Application number | Title of the application | Filing Date | Status |
---|
09/508550 | METHOD OF IN VIVO TRANSFORMATION UTILIZING LIPID VEHICLES | Mar 5, 2000 | Abandoned |
Array
(
[id] => 1415899
[patent_doc_number] => 06521602
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-18
[patent_title] => 'Anti-neoplastic compositions and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/516065
[patent_app_country] => US
[patent_app_date] => 2000-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 30
[patent_no_of_words] => 29269
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/521/06521602.pdf
[firstpage_image] =>[orig_patent_app_number] => 09516065
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/516065 | Anti-neoplastic compositions and uses thereof | Feb 29, 2000 | Issued |
Array
(
[id] => 1549460
[patent_doc_number] => 06346409
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-12
[patent_title] => 'Tryptophenyl tRNA synthetase from Streptococcus pneumoniae '
[patent_app_type] => B1
[patent_app_number] => 09/492581
[patent_app_country] => US
[patent_app_date] => 2000-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12321
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/346/06346409.pdf
[firstpage_image] =>[orig_patent_app_number] => 09492581
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/492581 | Tryptophenyl tRNA synthetase from Streptococcus pneumoniae | Jan 26, 2000 | Issued |
Array
(
[id] => 1554235
[patent_doc_number] => 06348585
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-19
[patent_title] => 'Human urotensin II'
[patent_app_type] => B1
[patent_app_number] => 09/477071
[patent_app_country] => US
[patent_app_date] => 2000-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9590
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/348/06348585.pdf
[firstpage_image] =>[orig_patent_app_number] => 09477071
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/477071 | Human urotensin II | Jan 2, 2000 | Issued |
09/470816 | HUMAN SCAD FAMILY MOLECULES | Dec 22, 1999 | Abandoned |
Array
(
[id] => 695841
[patent_doc_number] => 07071316
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-07-04
[patent_title] => 'Human Akt-3'
[patent_app_type] => utility
[patent_app_number] => 09/869079
[patent_app_country] => US
[patent_app_date] => 1999-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 11803
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/071/07071316.pdf
[firstpage_image] =>[orig_patent_app_number] => 09869079
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/869079 | Human Akt-3 | Dec 16, 1999 | Issued |
Array
(
[id] => 6242339
[patent_doc_number] => 20020045249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'DNA ENCODING OVINE ADENOVIRUS (OAV287) AND ITS USE AS A VIRAL VECTOR'
[patent_app_type] => new
[patent_app_number] => 09/464767
[patent_app_country] => US
[patent_app_date] => 1999-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 7554
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045249.pdf
[firstpage_image] =>[orig_patent_app_number] => 09464767
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/464767 | DNA encoding ovine adenovirus (OAV287) and its use as a viral vector | Dec 15, 1999 | Issued |
Array
(
[id] => 993815
[patent_doc_number] => 06916915
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-07-12
[patent_title] => 'Stressor regulated genes'
[patent_app_type] => utility
[patent_app_number] => 09/437450
[patent_app_country] => US
[patent_app_date] => 1999-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 47
[patent_no_of_words] => 8748
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/916/06916915.pdf
[firstpage_image] =>[orig_patent_app_number] => 09437450
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/437450 | Stressor regulated genes | Nov 9, 1999 | Issued |
09/421935 | DEFECTIVE ADENOVIRUSES AND CORRESPONDING COMPLEMENTATION LINES | Oct 20, 1999 | Abandoned |
09/416812 | SELECTIVELY REPLICATING VIRAL VECTORS | Oct 12, 1999 | Abandoned |
Array
(
[id] => 1360827
[patent_doc_number] => 06569677
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-27
[patent_title] => 'Modified adenoviral fiber and target adenoviruses'
[patent_app_type] => B1
[patent_app_number] => 09/402401
[patent_app_country] => US
[patent_app_date] => 1999-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11633
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/569/06569677.pdf
[firstpage_image] =>[orig_patent_app_number] => 09402401
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/402401 | Modified adenoviral fiber and target adenoviruses | Oct 3, 1999 | Issued |
Array
(
[id] => 4085919
[patent_doc_number] => 06133028
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-17
[patent_title] => 'Defective adenoviruses and corresponding complementation lines'
[patent_app_type] => 1
[patent_app_number] => 9/409670
[patent_app_country] => US
[patent_app_date] => 1999-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 22474
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/133/06133028.pdf
[firstpage_image] =>[orig_patent_app_number] => 409670
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/409670 | Defective adenoviruses and corresponding complementation lines | Sep 29, 1999 | Issued |
Array
(
[id] => 1541372
[patent_doc_number] => 06372208
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-16
[patent_title] => 'Method of reducing an immune response to a recombinant virus'
[patent_app_type] => B1
[patent_app_number] => 09/407490
[patent_app_country] => US
[patent_app_date] => 1999-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 17
[patent_no_of_words] => 13734
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/372/06372208.pdf
[firstpage_image] =>[orig_patent_app_number] => 09407490
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/407490 | Method of reducing an immune response to a recombinant virus | Sep 27, 1999 | Issued |
09/396875 | METHOD OF PRESERVING TISSUE VIABILITY DURING MECHANICAL SEPARATION PROCESS | Sep 14, 1999 | Abandoned |
Array
(
[id] => 1503080
[patent_doc_number] => 06465211
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-15
[patent_title] => 'Nucleic acids, vectors and transformed cells for making and using high affinity IP-3 binding polypeptides'
[patent_app_type] => B1
[patent_app_number] => 09/385222
[patent_app_country] => US
[patent_app_date] => 1999-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 22
[patent_no_of_words] => 23346
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/465/06465211.pdf
[firstpage_image] =>[orig_patent_app_number] => 09385222
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/385222 | Nucleic acids, vectors and transformed cells for making and using high affinity IP-3 binding polypeptides | Aug 25, 1999 | Issued |
Array
(
[id] => 5910771
[patent_doc_number] => 20020144302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => 'NOVEL CONSTRUCTS AND VECTORS FOR THE TARGETED AND INDUCIBLE EXPRESSION OF GENES'
[patent_app_type] => new
[patent_app_number] => 09/297910
[patent_app_country] => US
[patent_app_date] => 1999-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9459
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20020144302.pdf
[firstpage_image] =>[orig_patent_app_number] => 09297910
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/297910 | NOVEL CONSTRUCTS AND VECTORS FOR THE TARGETED AND INDUCIBLE EXPRESSION OF GENES | Aug 10, 1999 | Abandoned |
09/357675 | NITRILASE HOMOLOGS | Jul 19, 1999 | Abandoned |
09/353645 | RESPIRATION UNCOUPLING PROTEIN | Jul 14, 1999 | Abandoned |
Array
(
[id] => 4300313
[patent_doc_number] => 06251633
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-26
[patent_title] => 'Polynucleotides encoding Staphylococcus aureus FtsA polypeptide'
[patent_app_type] => 1
[patent_app_number] => 9/342459
[patent_app_country] => US
[patent_app_date] => 1999-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13803
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/251/06251633.pdf
[firstpage_image] =>[orig_patent_app_number] => 342459
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/342459 | Polynucleotides encoding Staphylococcus aureus FtsA polypeptide | Jun 28, 1999 | Issued |
Array
(
[id] => 1392115
[patent_doc_number] => 06541244
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-01
[patent_title] => 'Suppressor of cytokine signaling (SOCS)-3 promoter and methods for its use in genetic therapy in humans'
[patent_app_type] => B1
[patent_app_number] => 09/327138
[patent_app_country] => US
[patent_app_date] => 1999-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 15625
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/541/06541244.pdf
[firstpage_image] =>[orig_patent_app_number] => 09327138
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/327138 | Suppressor of cytokine signaling (SOCS)-3 promoter and methods for its use in genetic therapy in humans | Jun 6, 1999 | Issued |